Literature DB >> 22248591

Update on lipids and mitochondrial function: impact of dietary n-3 polyunsaturated fatty acids.

William C Stanley1, Ramzi J Khairallah, Erinne R Dabkowski.   

Abstract

PURPOSE OF REVIEW: Recent evidence has linked n-3 polyunsaturated fatty acid (PUFA) supplementation with dramatic alterations of mitochondrial phospholipid membranes and favorable changes in mitochondrial function. In the present review, we examine the novel effects of n-3 PUFA on mitochondria, with an emphasis on cardiac mitochondrial phospholipids. RECENT
FINDINGS: There is growing evidence that dietary n-3 PUFA, particularly docosahexaenoic acid (DHA), has profound effects on mitochondrial membrane phospholipid composition and mitochondrial function. Supplementation with n-3 PUFA increases membrane phospholipid DHA and depletes arachidonic acid, and can increase cardiolipin, a tetra-acyl phospholipid that is unique to mitochondrial and essential for optimal mitochondrial function. Recent studies show that supplementation with DHA decreases propensity for cardiac mitochondria to undergo permeability transition, a catastrophic event often leading to cell death. This finding provides a potential mechanism for the cardioprotective effect of DHA. Interestingly, other n-3 PUFAs that modify membrane composition to a lesser extent have substantially less of an effect on mitochondria and do not appear to directly protect the heart.
SUMMARY: Current data support a role for n-3 PUFA supplementation, particularly DHA, on mitochondria that are strongly associated with changes in mitochondrial phospholipid composition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22248591      PMCID: PMC4067133          DOI: 10.1097/MCO.0b013e32834fdaf7

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  30 in total

1.  Mitochondrial function in rats is affected by modification of membrane phospholipids with dietary sardine oil.

Authors:  S Yamaoka; R Urade; M Kito
Journal:  J Nutr       Date:  1988-03       Impact factor: 4.798

2.  Quantitation of cardiolipin molecular species in spontaneously hypertensive heart failure rats using electrospray ionization mass spectrometry.

Authors:  Genevieve C Sparagna; Chris A Johnson; Sylvia A McCune; Russell L Moore; Robert C Murphy
Journal:  J Lipid Res       Date:  2005-03-16       Impact factor: 5.922

3.  Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids.

Authors:  S Grimsgaard; K H Bonaa; J B Hansen; A Nordøy
Journal:  Am J Clin Nutr       Date:  1997-09       Impact factor: 7.045

4.  Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function.

Authors:  Salvatore Pepe; Peter L McLennan
Journal:  Circulation       Date:  2002-05-14       Impact factor: 29.690

5.  Phospholipid abnormalities in children with Barth syndrome.

Authors:  Michael Schlame; Richard I Kelley; Annette Feigenbaum; Jeffrey A Towbin; Paul M Heerdt; Thomas Schieble; Ronald J A Wanders; Salvatore DiMauro; Thomas J J Blanck
Journal:  J Am Coll Cardiol       Date:  2003-12-03       Impact factor: 24.094

6.  PUFA and aging modulate cardiac mitochondrial membrane lipid composition and Ca2+ activation of PDH.

Authors:  S Pepe; N Tsuchiya; E G Lakatta; R G Hansford
Journal:  Am J Physiol       Date:  1999-01

7.  Dietary omega-3 fatty acids alter cardiac mitochondrial phospholipid composition and delay Ca2+-induced permeability transition.

Authors:  Karen M O'Shea; Ramzi J Khairallah; Genevieve C Sparagna; Wenhong Xu; Peter A Hecker; Isabelle Robillard-Frayne; Christine Des Rosiers; Tibor Kristian; Robert C Murphy; Gary Fiskum; William C Stanley
Journal:  J Mol Cell Cardiol       Date:  2009-08-22       Impact factor: 5.000

8.  Influence of the phospholipid n-6/n-3 polyunsaturated fatty acid ratio on the mitochondrial oxidative metabolism before and after myocardial ischemia.

Authors:  L Demaison; J P Sergiel; D Moreau; A Grynberg
Journal:  Biochim Biophys Acta       Date:  1994-10-21

Review 9.  The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans.

Authors:  Trevor A Mori; Richard J Woodman
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2006-03       Impact factor: 4.294

10.  Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure.

Authors:  Genevieve C Sparagna; Adam J Chicco; Robert C Murphy; Michael R Bristow; Christopher A Johnson; Meredith L Rees; Melissa L Maxey; Sylvia A McCune; Russell L Moore
Journal:  J Lipid Res       Date:  2007-04-10       Impact factor: 5.922

View more
  42 in total

Review 1.  Omega-3 fatty acids, membrane remodeling and cancer prevention.

Authors:  Natividad R Fuentes; Eunjoo Kim; Yang-Yi Fan; Robert S Chapkin
Journal:  Mol Aspects Med       Date:  2018-04-12

2.  Dietary fat and fiber interactively modulate apoptosis and mitochondrial bioenergetic profiles in mouse colon in a site-specific manner.

Authors:  Yang-Yi Fan; Frederic M Vaz; Robert S Chapkin
Journal:  Eur J Cancer Prev       Date:  2017-07       Impact factor: 2.497

Review 3.  Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets.

Authors:  Hana M Zegallai; Grant M Hatch
Journal:  Mol Cell Biochem       Date:  2021-01-07       Impact factor: 3.396

4.  Enhanced resistance to permeability transition in interfibrillar cardiac mitochondria in dogs: effects of aging and long-term aldosterone infusion.

Authors:  Girma Asemu; Kelly A O'Connell; James W Cox; Erinne R Dabkowski; Wenhong Xu; Rogerio F Ribeiro; Kadambari C Shekar; Peter A Hecker; Sharad Rastogi; Hani N Sabbah; Charles L Hoppel; William C Stanley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-15       Impact factor: 4.733

5.  Omega-3 Fatty Acids and Mood Stabilizers Alter Behavioural and Energy Metabolism Parameters in Animals Subjected to an Animal Model of Mania Induced by Fenproporex.

Authors:  Kizzy Cancelier; Lara M Gomes; Milena Carvalho-Silva; Letícia J Teixeira; Joyce Rebelo; Isabella T Mota; Camila O Arent; Edemilson Mariot; Luiza W Kist; Maurício R Bogo; João Quevedo; Giselli Scaini; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2016-05-31       Impact factor: 5.590

6.  Docosahexaenoic acid supplementation alters key properties of cardiac mitochondria and modestly attenuates development of left ventricular dysfunction in pressure overload-induced heart failure.

Authors:  Erinne R Dabkowski; Kelly A O'Connell; Wenhong Xu; Rogerio F Ribeiro; Peter A Hecker; Kadambari Chandra Shekar; Caroline Daneault; Christine Des Rosiers; William C Stanley
Journal:  Cardiovasc Drugs Ther       Date:  2013-12       Impact factor: 3.727

7.  Dietary fatty acids specifically modulate phospholipid pattern in colon cells with distinct differentiation capacities.

Authors:  Jiřina Hofmanová; Josef Slavík; Petra Ovesná; Zuzana Tylichová; Jan Vondráček; Nicol Straková; Alena Hyršlová Vaculová; Miroslav Ciganek; Alois Kozubík; Lucie Knopfová; Jan Šmarda; Miroslav Machala
Journal:  Eur J Nutr       Date:  2016-03-16       Impact factor: 5.614

Review 8.  Mitochondrial dysfunction--a pharmacological target in Alzheimer's disease.

Authors:  Gunter P Eckert; Kathrin Renner; Schamim H Eckert; Janett Eckmann; Stephanie Hagl; Reham M Abdel-Kader; Christopher Kurz; Kristina Leuner; Walter E Muller
Journal:  Mol Neurobiol       Date:  2012-05-03       Impact factor: 5.590

Review 9.  Omega-3 fatty acid supplementation and cardiovascular disease.

Authors:  Donald B Jump; Christopher M Depner; Sasmita Tripathy
Journal:  J Lipid Res       Date:  2012-08-17       Impact factor: 5.922

Review 10.  Mechanisms by Which Dietary Fatty Acids Regulate Mitochondrial Structure-Function in Health and Disease.

Authors:  E Madison Sullivan; Edward Ross Pennington; William D Green; Melinda A Beck; David A Brown; Saame Raza Shaikh
Journal:  Adv Nutr       Date:  2018-05-01       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.